Sertoli Treated Cord Blood for Spinal Cord Injury

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43NS050065-01
Agency Tracking Number: NS050065
Amount: $150,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
SANERON CCEL THERAPEUTICS, INC.
3650 Spectrum Blvd., UTC II, Suite 170, TAMPA, FL, 33612
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 CYNDY Davis
 (813) 866-6372
 CDH@SANERON-CCEL.COM
Business Contact
 NICOLE KUZMIN-NICHOLS
Phone: (813) 866-6371
Email: NKN@SANERON-CCEL.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Stem cells from human umbilical cord blood (hUCB) represent a promising cellular therapeutic strategy for the treatment of cord injury (SCI). These cells are capable of differentiating into neurons and glia in vivo

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government